Julia A. Bridge
No Rating Available
(Learn About Our Rating System)

Julia A. Bridge, MD, FACMG

Languages spoken: English

Clinical Locations

Craig H. Neilsen Rehabilitation Hospital

Salt Lake City
801-646-8000

University of Utah Hospital

Pathology
Salt Lake City
801-581-2121

  • Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Medical Genetics (Clinical Cytogenetics)
    American Board of Pathology (Sub: Anatomic Path)

  • Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Medical Genetics (Clinical Cytogenetics)
    American Board of Pathology (Sub: Anatomic Path)

    Education history

    Fellowship Molecular Biology - Southwest Biomedical Research Institute Fellow
    Cytogenetics - University of Kansas Medical Center Special Fellow
    Fellowship Cytogenetics - University of Nebraska Medical Center Special Fellow
    Pathology - University of Kansas Medical Center Resident
    Undergraduate University of Nebraska Omaha B.S.
    Undergraduate University of Nebraska Omaha M.D.

    Selected Publications

    Journal Article

    1. Bridge JA, Halling KC, Moncur JT, Souers RJ, Hameed MR, Fernandes H, Roy A, Surrey L, Tafe LJ, Vasalos P, Lopez-Terrada DH (2023). RNA Sequencing for Solid Tumor Fusion Gene Detection: Proficiency Testing Practice and Performance Comparison. Arch Pathol Lab Med, 148(5), 538-544. (Read full article)
    2. Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge J, Claramunt R, Lpez-Guerrero JA, Alcacer J, Linos K, Llombart-Bosch A (2023). The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Arch, 484(5), 765-775. (Read full article)
    3. Machado I, Llombart-Bosch A, Charville GW, Navarro S, Domnguez Franjo MP, Bridge JA, Linos K (2023). Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1). Surg Pathol Clin, 17(1), 31-55. (Read full article)
    4. Mezzacappa FM, Smith FK, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Monforte HL, Liang J, Singh O, Quezado MM, Aldape KD, Gokden M, Bridge JA, Chen J (2024). Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor. Acta Neuropathol Commun, 12(1), 17. (Read full article)
    5. Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, Dolan M, Vasalos P, Kane ME, Souers RJ, Yemelyanova A (2022). Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Arch Pathol Lab Med, 147(10), 1148-1157. (Read full article)
    6. Crowley HM, Georgantzoglou N, Tse JY, Williams EA, Mata DA, Martin SS, Guitart J, Bridge JA, Linos K (2023). Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion. Am J Surg Pathol, 47(10), 1108-1115. (Read full article)
    7. Gangahar CN, Dehner CA, Wang DP, Amini B, Hillen T, OConor C, Jennings SN, Byrnes K, Montgomery EA, Czerniak BA, Bridge JA, Schroeder MC, Jennings JW, Wang WL, Chrisinger JSA (2023). Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases. Histopathology, 83(1), 40-48. (Read full article)
    8. Machado I, Hosler GA, Traves V, Claramunt R, Sanmartn O, Santonja C, Carvajal N, Zazo S, Requena L, Alfonso VS, Domenech EV, Llombart-Bosch A, Bridge JA, Linos K (2022). Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology. J Cutan Pathol, 50(6), 487-499. (Read full article)
    9. Zota V, Siegal GP, Kelly D, Bridge JA, Berglund A, Bui K, Khalil F, R Reed D, Altiok S, Magliocco A, Bui MM (2022). Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma. Fetal Pediatr Pathol, 42(2), 241-252. (Read full article)
    10. Acosta AM, Bridge JA, Dal Cin PS, Sholl LM, Cornejo KM, Fletcher CDM, Ulbright TM (2023). Inflammatory and Nested Testicular Sex Cord Tumor: A Novel Neoplasm With Aggressive Clinical Behavior and Frequent EWSR1::ATF1 Gene Fusions. Am J Surg Pathol, 47(4), 504-517. (Read full article)
    11. Bove JVMG, Webster F, Amary F, Baumhoer D, Bloem JLH, Bridge JA, Cates JMM, de Alava E, Dei Tos AP, Jones KB, Mahar A, Nielsen GP, Righi A, Wagner AJ, Yoshida A, Fletcher CDM (2022). Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 82(4), 531-540. (Read full article)
    12. Palsgrove DN, Rooper LM, Stevens TM, Shin C, Damm DD, Gagan J, Bridge JA, Thompson LDR, Koduru PR, Bishop JA (2022). GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH. Head Neck Pathol, 16(4), 1146-1156. (Read full article)
    13. Georgantzoglou N, Green D, Winnick KN, Sumegi J, Charville GW, Bridge JA, Linos K (2022). Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation. Genes Chromosomes Cancer, 61(8), 471-480. (Read full article)
    14. Brat DJ, Aldape K, Bridge JA, Canoll P, Colman H, Hameed MR, Harris BT, Hattab EM, Huse JT, Jenkins RB, Lopez-Terrada DH, McDonald WC, Rodriguez FJ, Souter LH, Colasacco C, Thomas NE, Yount MH, van den Bent MJ, Perry A (2021). Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. Arch Pathol Lab Med, 146(5), 547-574. (Read full article)
    15. Ramkissoon SH, Fernandes H, Lopez-Terrada DH, Hameed MR, Trembath DG, Bridge JA, Lindeman NI, Souers RJ, Vasalos P, Brat DJ, Moncur JT (2022). Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. Arch Pathol Lab Med, 147(5), 518-524. (Read full article)
    16. Strait AM, Bridge JA, Iafrate AJ, Li MM, Xu F, Tsongalis GJ, Linos K (2021). Mammary-type Myofibroblastoma with Leiomyomatous Differentiation: A Rare Variant with Potential Pitfalls. Int J Surg Pathol, 30(2), 200-206. (Read full article)
    17. Patton A, Bridge JA, Liebner D, Chung C, Iwenofu OH (2021). A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity! Genes Chromosomes Cancer, 61(4), 194-199. (Read full article)
    18. Campbell K, Bridge JA, DiMaio D, Wilson J, Shalin SC, Gardner JM (2021). Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations. J Cutan Pathol, 49(3), 274-277. (Read full article)
    19. Lindsey MS, Bridge JA, Douglas DS, Foster JT, Shalin SC, Gardner JM (2022). Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel Cell Carcinoma. Am J Dermatopathol, 44(3), 218-222. (Read full article)
    20. Cowan B, Klein E, Jansz K, Westenfelder K, Bradford T, Peterson C, Scherr D, Karsh LI, Egerdie B, Witjes A, Trainer A, Harris R, Goldfarb B, Flax S, Kroeger R, Boyd B, Liao J, Patel S, Bridge J, Reuter V, Quigley N, Brown S, Zhao S, Satya M, Bates M, Simon IM, Campbell S, Lotan Y (2021). Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert(®) Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer. BJU Int, 128(6), 713-721. (Read full article)
    21. Kerr DA, Thompson LDR, Tafe LJ, Jo VY, Neyaz A, Divakar P, Paydarfar JA, Pastel DA, Shirai K, John I, Seethala RR, Salgado CM, Deshpande V, Bridge JA, Kashofer K, Bri I, Linos K (2021). Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Am J Surg Pathol, 45(12), 1707-1719. (Read full article)
    22. Sadaf A, Szabo S, Ferguson K, Sorger JI, Sumegi J, Bridge JA, Pressey JG (2021). Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Cancer, 127(22), 4124-4130. (Read full article)
    23. Hughes CE, Correa H, Benedetti DJ, Smith B, Sumegi J, Bridge J (2021). Second Report of PDE10A-BRAF Fusion in Pediatric Spindle Cell Sarcoma With Infantile Fibrosarcoma-Like Morphology Suggesting PDE10A-BRAF Fusion Is a Recurrent Event. Pediatr Dev Pathol, 24(6), 554-558. (Read full article)
    24. Al-Obaidy KI, Bridge JA, Cheng L, Sumegi J, Reuter VE, Benayed R, Hameed M, Williamson SR, Hes O, Alruwaii FI, Segal JP, Wanjari P, Idrees MT, Nassiri M, Eble JN, Grignon DJ (2021). EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Mod Pathol, 34(10), 1921-1934. (Read full article)
    25. Parra O, Bridge JA, Busam KJ, Shalin SC, Linos K (2021). Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity. J Cutan Pathol, 48(7), 915-924. (Read full article)
    26. Wang H, Weiss VL, Hoffman RD, Abel T, Ho RH, Borinstein SC, Mannion K, Bridge JA, Black J, Liang J (2020). Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature. Head Neck Pathol, 15(1), 236-243. (Read full article)
    27. Motanagh S, Bridge JA, Linos K (2020). Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker. J Cutan Pathol, 48(2), 295-301. (Read full article)
    28. Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Lu X, Simon IM, Campbell SA, Bates MP, Higuchi RG, Witjes JA (2020). Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria. Eur Urol Oncol, 4(1), 93-101. (Read full article)
    29. Pettus JR, Kerr DA, Stan RV, Tse JY, Sverrisson EF, Bridge JA, Linos K (2020). Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1-FOXO4 fusion. Genes Chromosomes Cancer, 60(2), 116-122. (Read full article)
    30. Linos K, Kerr DA, Sumegi J, Bridge JA (2020). Pan-Trk immunoexpression in a superficial malignant ossifying fibromyxoid tumor with ZC3H7B-BCOR fusion: A potential obfuscating factor in the era of targeted therapy. J Cutan Pathol, 48(2), 340-342. (Read full article)
    31. Bridge JA, Sumegi J, Royce T, Baker M, Linos K (2020). A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. Genes Chromosomes Cancer, 60(1), 38-42. (Read full article)
    32. Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K (2020). A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol, 48(1), 95-101. (Read full article)
    33. Zhang L, Hwang S, Benayed R, Zhu GG, Mullaney KA, Rios KM, Sukhadia PY, Agaram N, Zhang Y, Bridge JA, Healey JH, Athanasian EA, Hameed M (2020). Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion. Mod Pathol, 33(8), 1492-1504. (Read full article)
    34. Tran TAN, Bridge JA, Deharvengt SJ, Green DC, Linos K (2019). Primary Cutaneous Adenomyoepithelioma Ex Spiradenoma With Malignant Histologic Features, Epithelial-Myoepithelial Carcinoma Type: A First Case Report With Molecular Studies. Int J Surg Pathol, 28(4), 427-435. (Read full article)
    35. Mindiola-Romero AE, Maloney N, Bridge JA, Korkolopoulou P, Sakellariou S, Linos K (2019). A concise review of angiofibroma of soft tissue: A rare newly described entity that can be encountered by dermatopathologists. J Cutan Pathol, 47(2), 179-185. (Read full article)
    36. Keegan A, Bridge JA, Lindeman NI, Long TA, Merker JD, Moncur JT, Montgomery ND, Nagarajan R, Rothberg PG, Routbort MJ, Vasalos P, Xian R, Kim AS (2020). Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies. Arch Pathol Lab Med. (Read full article)
    37. Maloney N, LeBlanc RE, Sriharan A, Bridge JA, Linos K (2019). Superficial Nodular Fasciitis With Atypical Presentations: Report of 3 Cases and Review of Recent Molecular Genetics. Am J Dermatopathol, 41(12), 931-936. (Read full article)
    38. Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS (2019). Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Mod Pathol, 32(11), 1593-1604. (Read full article)
    39. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS (2019). Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med, 143(10), 1203-1211. (Read full article)
    40. Maloney N, Bridge JA, de Abreu F, Korkolopoulou P, Sakellariou S, Linos K (2019). A novel MAP3K7CL-ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation. J Cutan Pathol, 46(7), 532-537. (Read full article)
    41. Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein-Weber M, Miettinen MM, Gatalica Z, Bridge JA (2019). NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol, 32(6), 764-773. (Read full article)
    42. MacKinnon WF, Carter MD, Bridge JA, Tremaine RD, Walsh NMG (2019). EWSR1-PBX3 gene fusion in cutaneous syncytial myoepithelioma. J Cutan Pathol, 46(6), 421-424. (Read full article)
    43. Nguyen JK, Bridge JA, Joshi C, McKenney JK (2018). Primary Mammary Analog Secretory Carcinoma (MASC) of the Vulva With ETV6-NTRK3 Fusion: A Case Report. Int J Gynecol Pathol, 38(3), 283-287. (Read full article)
    44. Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Shepard B, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Ge S, Zhao S, Simon IM, Campbell SA, Rhees B, Bates MP, Higuchi RG, Witjes JA (2018). Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol, 75(5), 853-860. (Read full article)
    45. Tran TAN, Linos K, Carlson JA, Bridge JA (2019). A primary cutaneous vascular neoplasm with histologic features of anastomosing hemangioma. J Cutan Pathol, 46(5), 353-357. (Read full article)
    46. Castillo SA, Pham AK, Barton DT, Lefferts JA, Yan S, Bridge JA, Linos K (2018). A diagnostically-challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23-gene expression signature (myPath melanoma). J Cutan Pathol, 46(3), 226-230. (Read full article)
    47. Maloley L, Helvey J, Bridge J, DiMaio D, Ghate D, Kedar S (2019). A Tough NUT to Crack: A 47-Year-Old With Diplopia From a Rare Malignancy. J Neuroophthalmol, 39(1), 129-133. (Read full article)
    48. Perkins AR, Macaulay RJB, Bui MM, Bridge JA, Etame AB (2019). A Frontal Dural-Based Lesion in a 63-Year Old Male. Brain Pathol, 29(2), 301-302. (Read full article)
    49. Maloney N, Giannikou K, Lefferts J, Bridge JA, Linos K (2018). Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. Hum Pathol, 82, 125-130. (Read full article)
    50. Olson N, Rouhi O, Zhang L, Angeles C, Bridge J, Lopez-Terrada D, Royce T, Linos K (2018). A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion. J Cutan Pathol, 45(12), 933-939. (Read full article)
    51. Tao JJ, Wei G, Patel R, Fagan P, Hao X, Bridge JA, Arcila ME, Al-Ahmadie H, Lee CH, Li G, Drilon A (2022). ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib. JCO Precis Oncol, 2, 1-8. (Read full article)
    52. Geiersbach KB, Bridge JA, Dolan M, Jennings LJ, Persons DL, Souers RJ, Tsuchiya KD, Vasalos PH, Moncur JT (2018). Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests. Arch Pathol Lab Med, 142(10), 1254-1259. (Read full article)
    53. Laetsch TW, Roy A, Xu L, Black JO, Coffin CM, Chi YY, Tian J, Spunt SL, Hawkins DS, Bridge JA, Parsons DW, Skapek SX (2018). Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group. Clin Cancer Res, 24(16), 3888-3897. (Read full article)
    54. Kim AS, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Moncur JT (2017). Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. JAMA Oncol, 4(6), 838-841. (Read full article)
    55. Hollowoa B, Lamps LW, Mizell JS, English GW 3rd, Bridge JA, Ram R, Gardner JM (2017). Dedifferentiated Liposarcoma Mimicking a Primary Colon Mass. Int J Surg Pathol, 26(2), 174-179. (Read full article)
    56. Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Goldfarb B, Liao JC (2017). Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection. J Urol, 199(3), 655-662. (Read full article)
    57. Borinstein SC, Steppan D, Hayashi M, Loeb DM, Isakoff MS, Binitie O, Brohl AS, Bridge JA, Stavas M, Shinohara ET, Meyer WH, Reed DR, Wagner LM (2017). Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer, 65(2). (Read full article)
    58. Kuba MG, Wasserman A, Vnencak-Jones CL, Bridge JA, Gellert L, Hameed O, Giannico GA (2016). Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway? Appl Immunohistochem Mol Morphol, 25(7), e49-e57. (Read full article)
    59. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, West WW, Wu H, Roden AC, Fujimoto J, Yu H, Anders R, Kowalewski A, Rivard C, Rehman J, Batenchuk C, Burns V, Hirsch FR, Wistuba II (2017). A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol, 3(8), 1051-1058. (Read full article)
    60. Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS (2017). Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer, 123(12), 2206-2218. (Read full article)
    61. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA, Otto K, Bridge JA, Bishop JA, Leon ME (2016). Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases. Head Neck Pathol, 11(2), 124-130. (Read full article)
    62. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA, Otto K, Bridge JA, Bishop JA, Leon ME (2016). Regarding Bocklage et al. "Regarding Dettloff et al. Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of First 3 Cases". Head Neck Pathol, 11(2), 266-267. (Read full article)
    63. McGregor SM, Alikhan MB, John RA, Kotler H, Bridge JA, Mujacic I, Kadri S, Segal J, Krausz T (2016). Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma. Am J Surg Pathol, 41(5), 717-722. (Read full article)
    64. Zajicek AK, Bridge JA, Akers JW, McGarry SV, Walker CW (2016). Dedifferentiated liposarcoma of the lower extremity with low-grade dedifferentiation and low-grade osteosarcomatous component. Skeletal Radiol, 46(2), 265-271. (Read full article)
    65. Bridge JA (2016). Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: Pre-analytic and analytic factors. Cancer Cytopathol, 125(1), 11-19. (Read full article)
    66. Hery AL, Ornvold K, Memoli V, Bridge J, Linos K (2016). A case of CIC-rearranged undifferentiated round-cell sarcoma with exclusive spindled morphology and diffuse CD99 positivity: a potential pitfall. Histopathology, 70(2), 314-316. (Read full article)
    67. Sholl LM, Andea A, Bridge JA, Cheng L, Davies MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar A, Raparia K, Siroy A, Watson KL, Members of Cancer Biomarker Reporting Committee College of American Pathologists (2015). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Arch Pathol Lab Med, 140(4), 355-7. (Read full article)
    68. Simons SA, Bridge JA, Leon ME (2015). Sinonasal small round blue cell tumors: An approach to diagnosis. Semin Diagn Pathol, 33(2), 91-103. (Read full article)
    69. Pages M, Lacroix L, Tauziede-Espariat A, Castel D, Daudigeos-Dubus E, Ridola V, Gilles S, Fina F, Andreiuolo F, Polivka M, Lechapt-Zalcman E, Puget S, Boddaert N, Liu XQ, Bridge JA, Grill J, Chretien F, Varlet P (2015). Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun, 3, 85. (Read full article)
    70. Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL, Childrens Oncology Group Ewing Sarcoma Biology Committee (2014). Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer, 62(5), 759-65. (Read full article)
    71. Smith SM, Coleman J, Bridge JA, Iwenofu OH (2015). Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors. J Surg Oncol, 111(5), 520-31. (Read full article)
    72. Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB (2014). Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis. Ultrastruct Pathol, 39(1), 69-77. (Read full article)
    73. Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, de Castro DG, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA (2014). Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial. J Clin Pathol, 68(2), 111-8. (Read full article)
    74. Gosmann C, Mattarollo SR, Bridge JA, Frazer IH, Blumenthal A (2014). IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. J Immunol, 193(5), 2248-57. (Read full article)
    75. Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL (2014). Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group. PLoS One, 9(8), e104378. (Read full article)
    76. Smith NE, Deyrup AT, Mario-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P (2014). VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol, 38(6), 858-63. (Read full article)
    77. Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M (2014). A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet, 46(6), 595-600. (Read full article)
    78. Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA, Parham DM (2014). Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol, 38(5), 654-9. (Read full article)
    79. Smith RE, Kebriaei MA, Gard AP, McComb RD, Bridge JA, Lennarson PJ (2013). Intracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature. Brain Tumor Pathol, 31(2), 149-54. (Read full article)
    80. Boyle TA, Bridge JA, Sabatini LM, Nowak JA, Vasalos P, Jennings LJ, Halling KC, College of American Pathologists Molecular Oncology Committee (2014). Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012. Arch Pathol Lab Med, 138(3), 363-70. (Read full article)
    81. Pauli C, Fuchs B, Pfirrmann C, Bridge JA, Hofer S, Bode B (2014). Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World J Surg Oncol, 12, 17. (Read full article)
    82. Bridge JA (2013). The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol, 27 Suppl 1, S80-97. (Read full article)
    83. Donnelly AD, Mukherjee MS, Lyden ER, Bridge JA, Lele SM, Wright N, McGaughey MF, Culberson AM, Horn AJ, Wedel WR, Radio SJ (2013). Optimal z-axis scanning parameters for gynecologic cytology specimens. J Pathol Inform, 4, 38. (Read full article)
    84. Viray H, Li K, Long TA, Vasalos P, Bridge JA, Jennings LJ, Halling KC, Hameed M, Rimm DL (2013). A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Arch Pathol Lab Med, 137(11), 1545-9. (Read full article)
    85. Nestheide S, Bridge JA, Barnes M, Frayer R, Sumegi J (2013). Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma. Pediatr Blood Cancer, 60(9), 1437-46. (Read full article)
    86. Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS (2013). PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer, 60(9), 1411-7. (Read full article)
    87. Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM (2013). Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol, 140(1), 82-90. (Read full article)
    88. Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM (2013). Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am J Surg Pathol, 37(5), 752-62. (Read full article)
    89. Cate F, Bridge JA, Crispens MA, Keedy VL, Troutman A, Coffin CM, Fadare O (2012). Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity? Hum Pathol, 44(4), 656-63. (Read full article)
    90. Bridge JA, Liu XQ, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD (2012). Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol, 23(2), 121-8. (Read full article)
    91. Edgar MA, Lauer SR, Bridge JA, Rizzo M (2012). Soft tissue angiofibroma: report of 2 cases of a recently described tumor. Hum Pathol, 44(3), 438-41. (Read full article)
    92. Perry AM, Nelson M, Sanger WG, Bridge JA, Greiner TC (2013). Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. In Vivo, 27(2), 211-4. (Read full article)
    93. Coleman MA, Bridge JA, Lane SW, Dixon CM, Hill GR, Wells JW, Thomas R, Steptoe RJ (2012). Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy. Blood, 121(6), 1049-58. (Read full article)
    94. Shulman SC, Katzenstein H, Bridge J, Bannister LL, Qayed M, Oskouei S, Shehata BM (2012). Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization. Fetal Pediatr Pathol, 31(6), 341-8. (Read full article)
    95. King L, Lpez-Terrada D, Jakacky J, McCarville MB, Spunt SL, Bridge JA, Bahrami A (2012). Primary intrathoracic dermatofibrosarcoma protuberans. Am J Surg Pathol, 36(12), 1897-902. (Read full article)
    96. Bridge JA, Sanders K, Huang D, Nelson M, Neff JR, Muirhead D, Walker C, Seemayer TA, Sumegi J (2012). Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone. Hum Pathol, 43(9), 1524-9. (Read full article)
    97. Pan Z, Sanger WG, Bridge JA, Hunter WJ, Siegal GP, Wei S (2012). A novel t(6;13)(q15;q34) translocation in a giant cell reparative granuloma (solid aneurysmal bone cyst). Hum Pathol, 43(6), 952-7. (Read full article)
    98. Behery RE, Bedrnicek J, Lazenby A, Nelson M, Grove J, Huang D, Smith R, Bridge JA (2012). Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma. Pediatr Dev Pathol, 15(3), 249-53. (Read full article)
    99. Bowen JM, Cates JM, Kash S, Itani D, Gonzalez A, Huang D, Oliveira A, Bridge JA (2012). Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet, 205(5), 249-54. (Read full article)
    100. Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge J, Wayne AS, Candotti F (2011). Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol, 129(3), 762-769.e1. (Read full article)
    101. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M (2011). Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer, 51(2), 127-39. (Read full article)
    102. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC (2011). PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. J Cancer Res Clin Oncol, 138(2), 213-20. (Read full article)
    103. Gatalica Z, Lilleberg SL, Monzon FA, Koul MS, Bridge JA, Knezetic J, Legendre B, Sharma P, McCue PA (2011). Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Hum Pathol, 42(12), 1979-88. (Read full article)
    104. Bowe SN, Ozer E, Bridge JA, Brooks JS, Iwenofu OH (2011). Primary intranodal epithelioid rhabdomyosarcoma. Am J Clin Pathol, 136(4), 587-92. (Read full article)
    105. Yasuda T, Suzuki K, Kanamori M, Hori T, Huang D, Bridge JA, Kimura T (2011). Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature. Oncol Rep, 26(3), 711-5. (Read full article)
    106. Riddle ND, Gonzalez RJ, Bridge JA, Antonia S, Bui MM (2011). A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma. Cancer Control, 18(3), 152-9. (Read full article)
    107. Hou J, Dong J, Sun L, Geng L, Wang J, Zheng J, Li Y, Bridge J, Hinrichs SH, Ding SJ (2011). Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. J Transl Med, 9, 64. (Read full article)
    108. Bridge JA, Cushman-Vokoun AM (2011). Molecular diagnostics of soft tissue tumors. Arch Pathol Lab Med, 135(5), 588-601. (Read full article)
    109. Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, Nagarajan R, Watson MA, Perry A (2011). Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res, 17(7), 1924-34. (Read full article)
    110. Shehata BM, Gupta NA, Katzenstein HM, Steelman CK, Wulkan ML, Gow KW, Bridge JA, Kenney BD, Thompson K, de Chadarvian JP, Abramowsky CR (2010). Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol, 14(2), 111-6. (Read full article)
    111. Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2010). Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol, 24(3), 430-42. (Read full article)
    112. Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA (2010). A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol, 24(3), 333-42. (Read full article)
    113. Steelman C, Katzenstein H, Parham D, Stockwell C, Ricketts R, Abramowsky C, Bridge JA, Sorensen PH, Kenney B, Olson T, Igbokwe A, Lopez-Terrada D, Shehata B (2011). Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis. Fetal Pediatr Pathol, 30(5), 329-37. (Read full article)
    114. Huang D, Sumegi J, Dal Cin P, Reith JD, Yasuda T, Nelson M, Muirhead D, Bridge JA (2010). C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes Chromosomes Cancer, 49(9), 810-8. (Read full article)
    115. Romeo S, Duim RA, Bridge JA, Mertens F, de Jong D, Dal Cin P, Wijers-Koster PM, Debiec-Rychter M, Sciot R, Rosenberg AE, Szuhai K, Hogendoorn PC (2010). Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes. Am J Pathol, 177(3), 1365-76. (Read full article)
    116. Nezelof C, Seemayer TA, Bridge JA (2009). Contributions of pediatrics and pediatric pathology to the body of knowledge regarding human disease. Hum Pathol, 41(3), 309-15. (Read full article)
    117. Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge JA (2009). Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer, 49(3), 224-36. (Read full article)
    118. Bridge JA, Bowen JM, Smith RB (2010). The small round blue cell tumors of the sinonasal area. Head Neck Pathol, 4(1), 84-93. (Read full article)
    119. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger WG (2009). An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. Br J Haematol, 148(4), 600-10. (Read full article)
    120. ODonnell PH, Jensen A, Posadas EM, Bridge JA, Yeldandi AV, Yang XJ, Stadler WM, Al-Ahmadie H (2010). Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nat Rev Urol, 7(2), 110-4. (Read full article)
    121. Monzon FA, Alvarez K, Gatalica Z, Bridge JA, Nelson M, Kim HJ, Hagenkord JM (2009). Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays. Arch Pathol Lab Med, 133(12), 1917-22. (Read full article)
    122. Giannico G, Holt GE, Homlar KC, Johnson J, Pinnt J, Bridge JA (2009). Osteoblastoma characterized by a three-way translocation: report of a case and review of the literature. Cancer Genet Cytogenet, 195(2), 168-71. (Read full article)
    123. Yasuda T, Nishio J, Sumegi J, Kapels KM, Althof PA, Sawyer JR, Reith JD, Bridge JA (2009). Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma. Mod Pathol, 22(11), 1499-506. (Read full article)
    124. Kim HJ, Shen SS, Ayala AG, Ro JY, Truong LD, Alvarez K, Bridge JA, Gatalica Z, Hagenkord JM, Gonzalez-Berjon JM, Monzon FA (2009). Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality. Am J Surg Pathol, 33(9), 1276-86. (Read full article)
    125. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL (2009). Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol, 33(5), 645-58. (Read full article)
    126. Nugent SL, Dim DC, Bridge JA, Ioffe OB (2009). Clear cell sarcoma of soft tissue metastatic to the ovaries: a heretofore unreported occurrence. Int J Gynecol Pathol, 28(3), 234-8. (Read full article)
    127. Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt R, Gnepp DR, Bridge JA (2008). Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol, 40(3), 341-8. (Read full article)
    128. Qualman S, Lynch J, Bridge J, Parham D, Teot L, Meyer W, Pappo A (2008). Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer, 113(11), 3242-7. (Read full article)
    129. Camp MD, Tompkins RK, Spanier SS, Bridge JA, Bush CH (2008). Best cases from the AFIP: Adamantinoma of the tibia and fibula with cytogenetic analysis. Radiographics, 28(4), 1215-20. (Read full article)
    130. Bridge JA (2008). Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms. J Orthop Sci, 13(3), 273-82. (Read full article)
    131. Rawlinson NJ, West WW, Nelson M, Bridge JA (2007). Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer Genet Cytogenet, 181(2), 119-24. (Read full article)
    132. Scanlan D, Radio SJ, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge JA (2007). Loss of the PTCH1 gene locus in cardiac fibroma. Cardiovasc Pathol, 17(2), 93-7. (Read full article)
    133. Bridge JA (2008). Contribution of cytogenetics to the management of poorly differentiated sarcomas. Ultrastruct Pathol, 32(2), 63-71. (Read full article)
    134. Torabi A, Lele SM, DiMaio D, Pinnt JC, Hess MM, Nelson M, Bridge JA (2007). Lack of a common or characteristic cytogenetic anomaly in solitary fibrous tumor. Cancer Genet Cytogenet, 181(1), 60-4. (Read full article)
    135. Streblow RC, Dafferner AJ, Nelson M, Fletcher M, West WW, Stevens RK, Gatalica Z, Novak D, Bridge JA (2007). Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. Cancer Genet Cytogenet, 178(2), 135-40. (Read full article)
    136. Kapels KM, Nishio J, Zhou M, Qualman SJ, Bridge JA (2006). Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation. Cancer Genet Cytogenet, 174(1), 68-73. (Read full article)
    137. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Schrock DS, Seemayer TA, Bridge JA (2007). Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. J Mol Diagn, 9(2), 144-50. (Read full article)
    138. Ellison DA, Parham DM, Bridge J, Beckwith JB (2006). Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol, 38(2), 205-11. (Read full article)
    139. Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS (2005). Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol, 176(1), 44-7. (Read full article)
    140. Nishio J, Gentry JD, Neff JR, Nelson M, Daniels W, Perry D, Gatalica Z, Bridge JA (2006). Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma. Virchows Arch, 448(6), 852-6. (Read full article)
    141. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA (2006). Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest, 86(6), 547-56. (Read full article)
    142. Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS (2005). No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett, 235(1), 136-40. (Read full article)
    143. Mazur MA, Gururangan S, Bridge JA, Cummings TJ, Mukundan S, Fuchs H, Larrier N, Halperin EC (2005). Intracranial Ewing sarcoma. Pediatr Blood Cancer, 45(6), 850-6. (Read full article)
    144. Nishio J, Reith JD, Ogose A, Maale G, Neff JR, Bridge JA (2005). Cytogenetic findings in clear cell chondrosarcoma. Cancer Genet Cytogenet, 162(1), 74-7. (Read full article)
    145. Olsen RJ, Lydiatt WM, Koepsell SA, Lydiatt D, Johansson SL, Naumann S, Bridge JA, Neff JR, Hinrichs SH, Tarantolo SR (2005). C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head Neck, 27(10), 883-92. (Read full article)
    146. Nishio J, Iwasaki H, Nabeshima K, Ishiguro M, Naumann S, Isayama T, Naito M, Kaneko Y, Kikuchi M, Bridge JA (2005). Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. Int J Oncol, 27(2), 361-9. (Read full article)
    147. Nishio J, Iwasaki H, Althof PA, Naumann S, Ishiguro M, Haraoka S, Iwashita A, Iwasaki A, Kaku Y, Kaneko Y, Kikuchi M, Bridge JA (2004). Identification of a ring chromosome with spectral karyotyping in a pleural synovial sarcoma. Cancer Genet Cytogenet, 160(2), 174-8. (Read full article)
    148. Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR, Demetri GD, Rosenberg AE, Bridge JA, Fletcher JA (2005). Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene, 24(21), 3419-26. (Read full article)
    149. Argani P, La M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M (2005). Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol, 29(2), 230-40. (Read full article)
    150. Caughron SK, Bridge JA, Bewtra CB, Hunter WJ, Nelson M, Soundararajan S, Silva E, Gatalica Z (2004). Monosomy 22 as a diagnostic aid in a case of late recurrence of adult granulosa cell tumor of the ovary. Cancer Genet Cytogenet, 156(1), 83-5. (Read full article)
    151. Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Bchler MW, Adrian TE, Batra SK, Pour PM (2005). ErbB2 growth factor receptor, a marker for neuroendocrine cells? Pancreatology, 5(1), 44-58. (Read full article)
    152. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH, Soft Tissue Sarcoma Committee of Childrens Oncology Group (2005). Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol, 8(1), 141. (Read full article)
    153. Deyrup AT, Althof P, Zhou M, Morgan M, Solomon AR, Bridge JA, Weiss SW (2004). Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol, 28(12), 1579-86. (Read full article)
    154. Bridge RS Jr, Bridge JA, Neff JR, Naumann S, Althof P, Bruch LA (2004). Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol, 57(11), 1172-8. (Read full article)
    155. Bernal KL, Fahmy L, Remmenga S, Bridge J, Baker J (2003). Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol, 95(1), 243-6. (Read full article)
    156. Cummings TJ, Bridge JA, Fukushima T (2004). Extraskeletal myxoid chondrosarcoma of the jugular foramen. Clin Neuropathol, 23(5), 232-7. (Read full article)
    157. Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann DH (2004). Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol, 14(3), 297-303. (Read full article)
    158. Althof PA, Ohmori K, Zhou M, Bailey JM, Bridge RS, Nelson M, Neff JR, Bridge JA (2004). Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol, 17(5), 518-25. (Read full article)
    159. Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher JA (2004). USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res, 64(6), 1920-3. (Read full article)
    160. Parham DM, Bridge JA, Lukacs JL, Ding Y, Tryka AF, Sawyer JR (2004). Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatr Dev Pathol, 7(2), 148-58. (Read full article)
    161. Bernal K, Nelson M, Neff JR, Nielsen SM, Bridge JA (2003). Translocation (2;11)(q31;q12) is recurrent in collagenous fibroma (desmoplastic fibroblastoma). Cancer Genet Cytogenet, 149(2), 161-3. (Read full article)
    162. Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B (2003). Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res, 9(15), 5442-53. (Read full article)
    163. Birch NC, Antonescu CR, Nelson M, Sarran L, Neff JR, Seemayer T, Bridge JA (2003). Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16). J Mol Diagn, 5(3), 191-4. (Read full article)
    164. Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C, Shipley J (2003). Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol, 16(8), 778-85. (Read full article)
    165. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EF, van Kessel AG (2003). Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet, 12(14), 1661-9. (Read full article)
    166. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA (2003). Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer, 37(1), 98-105. (Read full article)
    167. Nelson M, Perry D, Ginsburg G, Sanger WG, Neff JR, Bridge JA (2003). Translocation (1;4)(p31;q34) in nonossifying fibroma. Cancer Genet Cytogenet, 142(2), 142-4. (Read full article)
    168. Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA (2003). Cytogenetic findings in benign cartilaginous neoplasms. Cancer Genet Cytogenet, 141(2), 164-8. (Read full article)
    169. Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle Y (2003). The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res, 63(2), 449-54. (Read full article)
    170. Fritsch MK, Bridge JA, Schuster AE, Perlman EJ, Argani P (2002). Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Dev Pathol, 6(1), 43-53. (Read full article)
    171. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA (2002). Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer, 36(1), 7-16. (Read full article)
    172. Buddingh EP, Krallman P, Neff JR, Nelson M, Liu J, Bridge JA (2003). Chromosome 6 abnormalities are recurrent in synovial chondromatosis. Cancer Genet Cytogenet, 140(1), 18-22. (Read full article)
    173. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D, Osher G, Bridge JA, Anderson S, Johansson SL, Lieber M, Soloway M, Flom K (2002). Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol, 168(5), 1950-4. (Read full article)
    174. Folpe AL, McKenney JK, Bridge JA, Weiss SW (2002). Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol, 26(9), 1175-83. (Read full article)
    175. Feely MG, Boehm AK, Bridge RS, Krallman PA, Neff JR, Nelson M, Bridge JA (2002). Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Cancer Genet Cytogenet, 137(2), 102-7. (Read full article)
    176. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PH (2002). Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res, 62(16), 4704-10. (Read full article)
    177. Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA, Fisher C, Finlayson CJ, Shipley J, Houlston RS (2002). Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer, 87(4), 446-8. (Read full article)
    178. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG (2002). PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol, 20(11), 2672-9. (Read full article)
    179. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA (2002). Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol, 15(5), 572-6. (Read full article)
    180. Bridge JA, Liu J, Qualman SJ, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr FG (2002). Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer, 33(3), 310-21. (Read full article)
    181. Gisselsson D, Plsson E, Hglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl N (2002). Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer, 33(2), 133-40. (Read full article)
    182. Batanian JR, Bridge JA, Wickert R, Vogler C, Gadre B, Huang Y (2002). EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22). Cancer Genet Cytogenet, 133(1), 72-5. (Read full article)
    183. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O (2002). Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res, 62(1), 135-40. (Read full article)
    184. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M (2001). Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res, 7(12), 3977-87. (Read full article)
    185. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW (2001). Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol, 159(2), 411-5. (Read full article)
    186. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M (2001). Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol, 159(1), 179-92. (Read full article)
    187. Ladanyi M, Woodruff JM, Scheithauer BW, Bridge JA, Barr FG, Goldblum JR, Fisher C, Perez-Atayde A, Dal Cin P, Fletcher CD, Fletcher JA (2001). Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46. Mod Pathol, 14(7), 733-7. (Read full article)
    188. Aubry MC, Bridge JA, Wickert R, Tazelaar HD (2001). Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol, 25(6), 776-81. (Read full article)
    189. Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J (2001). Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer, 31(1), 54-64. (Read full article)
    190. Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR, Vergara G, Rosenthal H, Bridge JA (2001). Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol, 25(5), 684-7. (Read full article)
    191. McComb EN, Feely MG, Neff JR, Johansson SL, Nelson M, Bridge JA (2001). Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet, 126(1), 68-72. (Read full article)
    192. Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith JB (2001). Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol, 25(2), 133-46. (Read full article)
    193. Kanamori M, Antonescu CR, Scott M, Bridge RS Jr, Neff JR, Spanier SS, Scarborough MT, Vergara G, Rosenthal HG, Bridge JA (2001). Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. J Mol Diagn, 3(1), 16-21. (Read full article)
    194. Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, Bridge JA (2000). Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet, 120(2), 111-6. (Read full article)
    195. Ladanyi M, Bridge JA (2000). Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol, 31(5), 532-8. (Read full article)
    196. Bridge JA, Sandberg AA (2000). Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol, 29(5), 249-58. (Read full article)
    197. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG, Suijkerbuijk R (2000). Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet, 118(2), 89-98. (Read full article)
    198. Colleoni GW, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi M (2000). ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). Am J Pathol, 156(3), 781-9. (Read full article)
    199. Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, Bridge JA (2000). Recurrent anomalies of 6q25 in chondromyxoid fibroma. Hum Pathol, 31(3), 306-11. (Read full article)
    200. Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman F (2000). Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer, 82(4), 823-6. (Read full article)
    201. Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs SH (1999). Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem, 274(49), 34811-8. (Read full article)
    202. Buresh CJ, Seemayer TA, Nelson M, Neff JR, Dorfman HD, Bridge J (1999). t(X;4)(q22;q31.3) in giant cell reparative granuloma. Cancer Genet Cytogenet, 115(1), 80-1. (Read full article)
    203. Page TJ, Mata JE, Bridge JA, Siebler JC, Neff JR, Iversen PL (1999). The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells. Exp Cell Res, 252(1), 41-9. (Read full article)
    204. Rao VH, Singh RK, Delimont DC, Schaefer GB, Bridge JA, Neff JR, Sanger WG, Sappenfield JW, Buehler BA, Finnell RH (1999). Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone. J Interferon Cytokine Res, 19(10), 1207-17. (Read full article)
    205. Bridge JA, Swarts SJ, Buresh C, Nelson M, Degenhardt JM, Spanier S, Maale G, Meloni A, Lynch JC, Neff JR (1999). Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol, 154(3), 729-33. (Read full article)
    206. Rao VH, Singh RK, Delimont DC, Finnell RH, Bridge JA, Neff JR, Garvin BP, Pickering DL, Sanger WG, Buehler BA, Schaefer GB (1999). Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. Int J Oncol, 14(2), 291-300. (Read full article)
    207. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer TA (1999). Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol, 23(2), 159-65. (Read full article)
    208. Breiner JA, Nelson M, Bredthauer BD, Neff JR, Bridge JA (1999). Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet, 108(2), 176-7. (Read full article)
    209. Weibolt VM, Buresh CJ, Roberts CA, Suijkerbuijk RF, Pickering DL, Neff JR, Bridge JA (1998). Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet, 106(2), 177-9. (Read full article)
    210. Petit MM, Swarts S, Bridge JA, Van de Ven WJ (1998). Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma. Cancer Genet Cytogenet, 106(1), 18-23. (Read full article)
    211. Safar A, Wickert R, Nelson M, Neff JR, Bridge JA (1999). Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript. Diagn Mol Pathol, 7(5), 283-7. (Read full article)
    212. Aue G, Hedges LK, Schwartz HS, Bridge JA, Neff JR, Butler MG (1998). Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet, 105(1), 24-8. (Read full article)
    213. Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR (1998). Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer, 82(9), 1657-63. (Read full article)
    214. Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA (1998). Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res, (349), 189-93. (Read full article)
    215. Lawlor ER, Mathers JA, Bainbridge T, Horsman DE, Kawai A, Healey JH, Huvos AG, Bridge JA, Ladanyi M, Sorensen PH (1998). Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. J Clin Oncol, 16(3), 1150-7. (Read full article)
    216. Bridge JA, Roberts CA, Degenhardt J, Walker C, Lackner R, Linder J (1998). Low-level chromosome 12 amplification in a primary lipoma of the lung: evidence for a pathogenetic relationship with common adipose tissue tumors. Arch Pathol Lab Med, 122(2), 187-90. (Read full article)
    217. Day SJ, Nelson M, Rosenthal H, Vergara GG, Bridge JA (1997). Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer, 20(4), 425-7. (Read full article)
    218. McComb EN, Neff JR, Johansson SL, Nelson M, Bridge JA (1997). Chromosomal anomalies in a case of proliferative myositis. Cancer Genet Cytogenet, 98(2), 142-4. (Read full article)
    219. Cihak RA, Lydiatt WM, Lydiatt DD, Bridge JA (1997). Synovial sarcoma of the head and neck: chromosomal translation (X;18) as a diagnostic aid. Head Neck, 19(6), 549-53. (Read full article)
    220. Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA, Sawaya R, Nicolson GL, Rao JS (1997). Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clin Exp Metastasis, 15(4), 400-9. (Read full article)
    221. Krause AK, Hinrichs SH, Orndal C, DeBoer J, Neff JR, Bridge JA (1997). Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931. Cancer Genet Cytogenet, 94(2), 138-43. (Read full article)
    222. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M (1997). Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol, 150(3), 1049-58. (Read full article)
    223. McComb EN, McComb RD, DeBoer JM, Neff JR, Bridge JA (1996). Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature. Cancer Genet Cytogenet, 91(1), 8-12. (Read full article)
    224. Swarts S, Wisecarver J, Bridge JA (1996). Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma. Cancer Genet Cytogenet, 91(1), 65-7. (Read full article)
    225. Swarts SJ, Neff JR, Johansson SL, Bridge JA (1996). Cytogenetic analysis of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet, 89(1), 49-51. (Read full article)
    226. Bridge JA (1996). Cytogenetics and experimental models. Curr Opin Oncol, 8(4), 284-8. (Read full article)
    227. McComb EN, Johansson SL, Neff JR, Nelson M, Bridge JA (1996). Chromosomal anomalies exclusive of telomeric associations in giant cell tumor of bone. Cancer Genet Cytogenet, 88(2), 163-6. (Read full article)
    228. Roberts CA, Seemayer TA, Neff JR, Alonso A, Nelson M, Bridge JA (1996). Translocation (X;18) in primary synovial sarcoma of the lung. Cancer Genet Cytogenet, 88(1), 49-52. (Read full article)
    229. Wang Z, Taylor AK, Bridge JA (1996). FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet, 33(5), 376-8. (Read full article)
    230. Rao VH, Bridge JA, Neff JR, Schaefer GB, Buehler BA, Vishwanatha JK, Pollock RE, Nicolson GL, Yamamoto M, Gokaslam ZL (1995). Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis, 13(6), 420-6. (Read full article)
    231. Bridge JA (1995). Cytogenetics and experimental models of sarcomas. Curr Opin Oncol, 7(4), 333-9. (Read full article)
    232. Bridge JA, DeBoer J, Walker CW, Neff JR (1995). Translocation t(3;12)(q28;q14) in parosteal lipoma. Genes Chromosomes Cancer, 12(1), 70-2. (Read full article)
    233. Sinovic J, Bridge JA (1994). Translocation (2;17) in recurrent dermatofibrosarcoma protuberans. Cancer Genet Cytogenet, 75(2), 156-7. (Read full article)
    234. Bridge JA, Pickering D, Neff JR (1994). Cytogenetic and molecular cytogenetic analysis of sacral chordoma. Cancer Genet Cytogenet, 75(1), 23-5. (Read full article)
    235. Bridge JA, Dembinski A, DeBoer J, Travis J, Neff JR (1994). Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer, 73(6), 1746-52. (Read full article)
    236. Bridge JA, DeBoer J, Travis J, Johansson SL, Elmberger G, Noel SM, Neff JR (1994). Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol, 144(2), 215-20. (Read full article)
    237. Travis JA, Sandberg AA, Neff JR, Bridge JA (1994). Cytogenetic findings in malignant triton tumor. Genes Chromosomes Cancer, 9(1), 1-7. (Read full article)
    238. Bridge JA, Bhatia PS, Anderson JR, Neff JR (1993). Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet, 69(2), 79-90. (Read full article)
    239. Tayyeb MT, Neff JR, Bridge JA (1993). A case report of fibrolipoma with t(12;16)(q13;q24). Cancer Genet Cytogenet, 67(2), 145-6. (Read full article)
    240. Bridge JA (1993). Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery. J Bone Joint Surg Am, 75(4), 606-14. (Read full article)
    241. Travis JA, Bridge JA (1992). Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet, 64(2), 104-6. (Read full article)
    242. Stephenson CF, Bridge JA, Sandberg AA (1992). Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors. Hum Pathol, 23(11), 1270-7. (Read full article)
    243. DeBoer JM, Neff JR, Bridge JA (1992). Cytogenetics of sacral chordoma. Cancer Genet Cytogenet, 64(1), 95-6. (Read full article)
    244. Meloni AM, Bridge J, Sandberg AA (1992). Reviews on chromosome studies in urological tumors. I. Renal tumors. J Urol, 148(2 Pt 1), 253-65. (Read full article)
    245. Sinovic JF, Bridge JA, Neff JR (1992). Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance. Cancer Genet Cytogenet, 62(1), 50-2. (Read full article)
    246. Dembinski A, Bridge JA, Neff JR, Berger C, Sandberg AA (1992). Trisomy 2 in proliferative fasciitis. Cancer Genet Cytogenet, 60(1), 27-30. (Read full article)
    247. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman SR (1992). Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer, 69(2), 430-6. (Read full article)
    248. Bridge JA, Persons DL, Neff JR, Bhatia P (1992). Clonal karyotypic aberrations in enchondromas. Cancer Detect Prev, 16(4), 215-9. (Read full article)
    249. Sandberg AA, Bridge JA (1992). Techniques in cancer cytogenetics: an overview and update. Cancer Invest, 10(2), 163-72. (Read full article)
    250. Bridge JA, Neff JR, Mouron BJ (1992). Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet, 58(1), 2-13. (Read full article)
    251. Bridge JA, Mouron BJ, Neff JR, Bhatia PS (1991). Significance of chromosomal abnormalities in a malignant giant cell tumor of bone. Cancer Genet Cytogenet, 57(1), 87-92. (Read full article)
    252. Pfeifer FM, Bridge JA, Neff JR, Mouron BJ (1991). Cytogenetic findings in aneurysmal bone cysts. Genes Chromosomes Cancer, 3(6), 416-9. (Read full article)
    253. Bridge J, Leong SP, Burgess AC, Thompson F, Trent JM (1991). Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis. Melanoma Res, 1(4), 289-96. (Read full article)
    254. Persons DL, Bridge JA, Neff JR (1991). Cytogenetic analysis of two sacral chordomas. Cancer Genet Cytogenet, 56(2), 197-201. (Read full article)
    255. Sreekantaiah C, Bridge JA, Rao UN, Neff JR, Sandberg AA (1991). Clonal chromosomal abnormalities in hemangiopericytoma. Cancer Genet Cytogenet, 54(2), 173-81. (Read full article)
    256. Bridge JA, Sreekantaiah C, Neff JR, Sandberg AA (1991). Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet, 52(1), 101-6. (Read full article)
    257. Meloni A, Morgan R, Bridge J, Erling MA, Lewin RJ, Sandberg AA (1991). Cytogenetic findings in typical and atypical meningioma. Cancer Genet Cytogenet, 51(1), 35-9. (Read full article)
    258. Bridge JA, Neff JR, Sandberg AA (1990). Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet, 49(2), 199-202. (Read full article)
    259. Bridge JA, Neff JR, Borek DA, Hackbarth DA (1990). Primary skeletal Ewing's sarcoma in Down syndrome. Cancer Genet Cytogenet, 47(1), 61-8. (Read full article)
    260. Bridge JA, Neff JR, Bhatia PS, Sanger WG, Murphey MD (1990). Cytogenetic findings and biologic behavior of giant cell tumors of bone. Cancer, 65(12), 2697-703. (Read full article)
    261. Bridge JA, Sanger WG, Neff JR, Hess MM (1990). Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology, 22(1), 16-9. (Read full article)
    262. Bridge JA, Neff JR, Bhatia PS, Sanger WG (1990). Cytogenetic analysis of giant cell tumors of bone; diagnostic and prognostic implications. Chir Organi Mov, 75(1 Suppl), 187-8. (Read full article)
    263. Bridge JA, Borek DA, Neff JR, Huntrakoon M (1990). Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol, 93(1), 26-31. (Read full article)
    264. Kepes JJ, Bridge JA, Flasschoen J (1990). Penetration of neuronal perikarya by capillaries in chronic limbic encephalitis. J Neuropathol Exp Neurol, 49(1), 64-70. (Read full article)
    265. Bridge JA, McManus BM, Remmenga J, Cuppage FP (1989). Complete heart block in the 18p--syndrome. Congenital calcification of the atrioventricular node. Arch Pathol Lab Med, 113(5), 539-41. (Read full article)
    266. Bridge JA, Sanger WG, Neff JR (1989). Translocations involving chromosomes 2 and 13 in benign and malignant cartilaginous neoplasms. Cancer Genet Cytogenet, 38(1), 83-8. (Read full article)
    267. Bridge JA, Bridge RS, Borek DA, Shaffer B, Norris CW (1988). Translocation t(X;18) in orofacial synovial sarcoma. Cancer, 62(5), 935-7. (Read full article)
    268. Bridge J, Patil S, Peterson J, Speaks S, Fatemi C, Williamson R, Sanger W (1988). Two double translocation families. Kans Med, 89(2), 46-8. (Read full article)
    269. Sanger WG, Armitage JO, Bridge J, Weisenburger DD, Fordyce R, Purtilo DT (1987). Initial and subsequent cytogenetic studies in malignant lymphoma. Cancer, 60(12), 3014-9. (Read full article)
    270. Bridge JA, Sanger WG, Shaffer B, Neff JR (1987). Cytogenetic findings in malignant fibrous histiocytoma. Cancer Genet Cytogenet, 29(1), 97-102. (Read full article)
    271. Bridge J, Sanger W, Mosher G, Buehler B, Hearty C, Olney A, Fordyce R (1985). Partial duplication of distal 17q. Am J Med Genet, 22(2), 229-35. (Read full article)
    272. Bridge J, Sanger W, Mosher G, Buehler B, Nelson R, Welsh M, Newland J, Kafka M (1985). Partial deletion of distal 17q. Am J Med Genet, 21(2), 225-9. (Read full article)

    Review

    1. McMullen PD, Bridge JA, Blair EA, Yang CW, Collins J, Cipriani NA (2018). Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature. [Review]. Head Neck Pathol, 13(3), 281-285. (Read full article)
    2. Banach BS, Antic T, Bridge JA, Cipriani NA, Frye L, Krausz TN, Biernacka A (2019). Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review. [Review]. Diagn Cytopathol, 47(8), 797-802. (Read full article)
    3. Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Lindeman NI, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD (2017). A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. [Review]. Arch Pathol Lab Med, 141(12), 1679-1685. (Read full article)
    4. Torabi A, Corral J, Gatalica Z, Swensen J, Moraveji S, Bridge JA (2017). Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature. [Review]. Pathology, 49(4), 447-450. (Read full article)
    5. Fang D, Gan H, Lee JH, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, Bridge JA, Thibodeau SN, Ordog T, Chen Y, van Wijnen AJ, Oliveira AM, Xu RM, Westendorf JJ, Zhang Z (2016). The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. [Review]. Science, 352(6291), 1344-8. (Read full article)
    6. Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME (2016). Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. [Review]. Histopathology, 68(7), 1040-5. (Read full article)
    7. Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde AR, Marino-Enriquez A, Fletcher JA, Geller JI, Leuer KM, Bridge JA, Perlman EJ (2016). ALK-rearranged renal cell carcinomas in children. [Review]. Genes Chromosomes Cancer, 55(5), 442-51. (Read full article)
    8. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge JA, Buyukeren B, Aki FT (2015). Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. [Review]. Diagn Pathol, 10, 186. (Read full article)
    9. Sandberg AA, Bridge JA (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. [Review]. Cancer Genet Cytogenet, 145(1), 1-30. (Read full article)
    10. Sandberg AA, Bridge JA (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. [Review]. Cancer Genet Cytogenet, 143(1), 1-31. (Read full article)
    11. Sandberg AA, Bridge JA (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. [Review]. Cancer Genet Cytogenet, 140(1), 1-12. (Read full article)
    12. Sandberg AA, Bridge JA (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. desmoplastic small round-cell tumors. [Review]. Cancer Genet Cytogenet, 138(1), 1-10. (Read full article)
    13. Sandberg A, Bridge J (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma. [Review]. Cancer Genet Cytogenet, 136(1), 1-9. (Read full article)
    14. Sandberg AA, Bridge JA (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. gastrointestinal stromal tumors. [Review]. Cancer Genet Cytogenet, 135(1), 1-22. (Read full article)
    15. Sandberg AA, Bridge JA (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. [Review]. Cancer Genet Cytogenet, 133(1), 1-23. (Read full article)
    16. Sandberg AA, Bridge JA (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma. [Review]. Cancer Genet Cytogenet, 132(1), 1-13. (Read full article)
    17. Sandberg AA, Bridge JA (2001). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). [Review]. Cancer Genet Cytogenet, 130(1), 1-7. (Read full article)
    18. Sandberg AA, Bridge JA (2001). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma. [Review]. Cancer Genet Cytogenet, 127(2), 93-110. (Read full article)
    19. Sandberg AA, Bridge JA (2000). Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. [Review]. Cancer Genet Cytogenet, 123(1), 1-26. (Read full article)
    20. Feely MG, Fidler ME, Nelson M, Neff JR, Bridge JA (2000). Cytogenetic findings in a case of epithelioid sarcoma and a review of the literature. [Review]. Cancer Genet Cytogenet, 119(2), 155-7. (Read full article)
    21. Swarts SJ, Neff JR, Nelson M, Johansson S, Bridge JA (1997). Chromosomal abnormalities in low grade chondrosarcoma and a review of the literature. [Review]. Cancer Genet Cytogenet, 98(2), 126-30. (Read full article)
    22. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR (1997). Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. [Review]. Cancer Genet Cytogenet, 95(1), 74-87. (Read full article)
    23. Bridge JA, Rosenthal H, Sanger WG, Neff JR (1989). Desmoplastic fibroma arising in fibrous dysplasia. Chromosomal analysis and review of the literature. [Review]. Clin Orthop Relat Res, (247), 272-8. (Read full article)

    Case Report

    1. Dawson K, Bridge JA, Sumegi J, Royce T, Gardner JM, Shalin SC (2020). Epithelioid Fibrous Histiocytoma With Dot-Like Perinuclear ALK Expression and PRKAR2A-ALK Fusion. Am J Dermatopathol, 42(11), 861-864. (Read full article)
    2. Linos K, Kerr DA, Baker M, Wong S, Henderson E, Sumegi J, Bridge JA (2020). Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions. J Cutan Pathol, 47(10), 934-945. (Read full article)
    3. Murphy LD, Orman GM, Bridge JA, Bajaj G, Gardner JM, Douglass DP (2020). Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss. J Cutan Pathol, 47(10), 970-975. (Read full article)
    4. Keung ES, Souers RJ, Bridge JA, Faquin WC, Graham RP, Hameed MR, Lewis JS Jr, Merker JD, Vasalos P, Moncur JT (2019). Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests. Arch Pathol Lab Med, 144(3), 344-349. (Read full article)
    5. McComb EN, Neff JR, Johansson SL, Nelson M, Bridge JA (1997). Chromosomal anomalies in a case of proliferative myositis. Cancer Genet Cytogenet, 98(2), 142-4. (Read full article)
    6. Kenny-Moynihan MB, Hagen J, Richman B, McIntosh DG, Bridge JA (1996). Loss of an X chromosome in aggressive angiomyxoma of female soft parts: a case report. Cancer Genet Cytogenet, 89(1), 61-4. (Read full article)

    Letter

    1. Nicholas BA, Purohit R, Woods AD, Kannan K, Srinivasa G, Bridge JA, Kim JA, Keller C (2023). BCR-ABL is enriched in S- and G(2)-cell cycle phases. [Letter to the editor]. Leuk Res, 126, 107036. (Read full article)
    2. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, Roden AC, Hirsch FR, Wistuba II, Pusztai L (2019). Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer. [Letter to the editor]. Breast Cancer Res, 21(1), 72. (Read full article)
    3. Linos K, Bridge JA, Edgar MA (2014). MUC 4-negative FUS-CREB3L2 rearranged low-grade fibromyxoid sarcoma. [Letter to the editor]. Histopathology, 65(5), 722-4. (Read full article)
    4. Ganesan J, Spanier S, Bridge JA (2000). Cytogenetic findings in a case of brown tumor associated with hyperparathyroidism. [Letter to the editor]. Cancer Genet Cytogenet, 119(2), 165-6. (Read full article)
    5. Bridge JA, Meloni AM, Neff JR, Deboer J, Pickering D, Dalence C, Jeffrey B, Sandberg AA (1996). Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number. [Letter to the editor]. Cancer Genet Cytogenet, 92(2), 150-1. (Read full article)
    6. Bridge JA, Shaffer B, Neff JR, Sanger WG, Moran J (1988). A complex translocation involving chromosomes 12 and 16 in a metastatic myxoid liposarcoma. [Letter to the editor]. Cancer Genet Cytogenet, 34(1), 119-20. (Read full article)